{"title": "Manifestaciones cl\u00ednicas y respuesta al COVID-19 en adultos con d\u00e9ficit completo de inmunoglobulina A", "author": "Pino L\u00f3pez; Rosal\u00eda del Carmen", "url": null, "hostname": null, "description": "Traballo Fin de Grao en Medicina. Curso 2021-2022", "sitename": null, "date": "2022-06-21", "id": null, "license": "CC BY-NC-SA 4.0", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Manifestaciones cl\u00ednicas y respuesta al COVID-19 en adultos con d\u00e9ficit completo de inmunoglobulina A\nPor favor, use este identificador para citas ou ligaz\u00f3ns a este \u00edtem:\nhttp://hdl.handle.net/10347/29818\nFicheiros no \u00edtem\nMetadatos do \u00edtem\n|T\u00edtulo:||Manifestaciones cl\u00ednicas y respuesta al COVID-19 en adultos con d\u00e9ficit completo de inmunoglobulina A\n|\n|Outro/s t\u00edtulo/s:||Manifestaci\u00f3ns cl\u00ednicas e resposta ao COVID-19 en adultos con d\u00e9ficit completo de inmunoglobulina A\n|\nClinical manifestations and COVID-19 response in adults with complete immunoglobulin A deficiency\n|Autor/a:||\n|[Sope\u00f1a P\u00e9rez-Arg\u00fcelles, Bernardo](/xmlui/browse?value=Sope%C3%B1a+P%C3%A9rez-Arg%C3%BCelles%2C+Bernardo&type=author)\n[Freire Dapena, Mar\u00eda del Carmen](/xmlui/browse?value=Freire+Dapena%2C+Mar%C3%ADa+del+Carmen&type=author)\n[D\u00e9ficit selectivo de IgA](/xmlui/browse?value=D%C3%A9ficit+selectivo+de+IgA&type=subject)| [Covid-19](/xmlui/browse?value=Covid-19&type=subject)| [Alergia](/xmlui/browse?value=Alergia&type=subject)| [Enfermedad cel\u00edaca](/xmlui/browse?value=Enfermedad+cel%C3%ADaca&type=subject)| [Autoinmunidad](/xmlui/browse?value=Autoinmunidad&type=subject)| [Alerxia](/xmlui/browse?value=Alerxia&type=subject)| [Enfermidade cel\u00edaca](/xmlui/browse?value=Enfermidade+cel%C3%ADaca&type=subject)| [Autoinmunidade](/xmlui/browse?value=Autoinmunidade&type=subject)| [Selective IgA deficiency](/xmlui/browse?value=Selective+IgA+deficiency&type=subject)| [Allergy](/xmlui/browse?value=Allergy&type=subject)| [Celiac Disease](/xmlui/browse?value=Celiac+Disease&type=subject)| [Autoimmunity](/xmlui/browse?value=Autoimmunity&type=subject)|\nINTRODUCI\u00d3N: O d\u00e9ficit selectivo de IgA (DSIgA) \u00e9 unha entidade infradiagnosticada e escasamente co\u00f1ecida, considerada pouco relevante porque a maior\u00eda ser\u00e1n asintom\u00e1ticos. Esta opini\u00f3n expl\u00edcase porque moitos estudos son pedi\u00e1tricos e historicamente inclu\u00edron o d\u00e9ficit parcial de IgA. O presente traballo foi dese\u00f1ado para identificar as manifestaci\u00f3ns cl\u00ednicas m\u00e1is importantes do DSIgA en adultos, e a s\u00faa resposta serol\u00f3xica e de gravidade ao Covid-19. PACIENTES E M\u00c9TODO: Estudo prospectivo de pacientes adultos con DSIgA seguidos por Medicina Interna do Hospital Cl\u00ednico de Santiago, e os detectados nun estudo prevalencia en poboaci\u00f3n sa. A todos realiz\u00f3uselles entrevista dirixida, anal\u00edtica espec\u00edfica, serolox\u00eda SARS- CoV-2 e historia de Covid-19. RESULTADOS: Inclu\u00edronse 19 adultos, 13 eran mulleres (68%) cunha idade media de 40,7\u00b110,6 anos (rango: 23-70). En 5 (26%) o DSIgA diagnosticouse no estudo poboacional (grupo asintom\u00e1tico). Atop\u00e1ronse trazas de IgA no 38%, deficiencia selectiva de IgE en 9 (47%), deficiencia de subclases de IgG en 2, e 1 evolucionou a inmunodeficiencia com\u00fan variable. Atop\u00e1ronse autoanticorpos no 47%, os m\u00e1is frecuentes foron os ANA, e unha paciente asintom\u00e1tica presentou anti- transglutaminasa a t\u00edtulo moi alto. Padec\u00edan infecci\u00f3ns recorrentes un 88%, alerxia 31% (asma e/ou rinites en todos), enfermidades autoinmunes 76%, en 8 graves (unha faleceu por anemia hemol\u00edtica autoinmune), intolerancia \u00e1 lactosa 4/9 e tumores 21%. Os grupos de DSIgA sintom\u00e1tico e asintom\u00e1tico non diferiron significativamente en ning\u00fan destes aspectos, tampouco na resposta serol\u00f3xica e cl\u00ednica ao COVID-19 que padeceron o 61% sen precisar ingreso. CONCLUSI\u00d3NS: A maior\u00eda de pacientes con DSIgA presentaron manifestaci\u00f3ns cl\u00ednicas relevantes (infecci\u00f3ns, enfermidades autoinmunes, d\u00e9ficit de lactasa ou cel\u00edaca, alerxias e neoplasias). A resposta serol\u00f3xica \u00e1 vacina SARS- CoV-2 foi excelente e non houbo casos COVID-19 grave ou recorrente\nINTRODUCTION: Selective IgA deficiency (SIgAD) is an underdiagnosed and poorly understood entity, considered of little relevance because most will be asymptomatic. This opinion is explained by the fact that many studies are pediatric and have historically included partial IgA deficiency. The present work was designed to identify the most important clinical manifestations of SIgAD in adults, and its serological and severity response to Covid-19. PATIENTS AND METHOD: Prospective study of adult patients with SIgAD followed up in Internal Medicine at the Clinical Hospital of Santiago, and those detected in a prevalence study in a healthy population. All of them underwent a targeted interview, specific analysis, SARS-CoV-2 serology and history of Covid-19. RESULTS: 19 adults were included, 13 were women (68%) with a mean age of 40,7\u00b110,6 years (range: 23-70). In 5 (26%) SIgAD was diagnosed in the population study (asymptomatic group). Traces of IgA were found in 38%, selective IgE deficiency in 7 (38%), IgG subclass deficiency in 2, and 1 evolved to common variable immunodeficiency. Autoantibodies were found in 47%, the most frequent being ANA, and one asymptomatic patient presented anti-transglutaminase at a very high titer. 88% had recurrent infections, 31% allergies (asthma and/or rhinitis in all), 76% autoimmune diseases, 8 serious ones (one died of autoimmune hemolytic anemia), 4/9 lactose intolerance, and 21% tumors. The symptomatic and asymptomatic SIgAD groups did not differ significantly in any of these aspects, nor in the serological and clinical response to COVID-19, which 61% suffered without requiring admission. CONCLUSIONS: The majority of patients with SIgAD presented relevant clinical manifestations (infections, autoimmune diseases, lactase or celiac deficiency, allergies and neoplasia). The serological response to the SARS-CoV-2 vaccine was excellent and there were no severe or recurrent COVID-19 cases\n[http://hdl.handle.net/10347/29818](http://hdl.handle.net/10347/29818)\nColecci\u00f3ns\n-\n-\n[Grao en Medicina](/xmlui/handle/10347/11485)[276]\n-\nO \u00edtem ten asociados os seguintes ficheiros de licenza:", "language": null, "image": null, "pagetype": null, "links": ["/xmlui/?locale-attribute=gl", "/xmlui/?locale-attribute=es", "/xmlui/?locale-attribute=en", "https://biblioteca-usc.gal/guia/minerva/", "https://biblioteca-usc.gal/guia/guia-de-autoarquivo-en-minerva/", "https://biblioteca-usc.gal/guia/dereitos-de-autor-e-acceso-aberto/", "https://minerva.usc.es/xmlui/contact", "http://www.usc.es/", "/xmlui/login", "#", "/xmlui/", "/xmlui/handle/10347/6394", "/xmlui/handle/10347/6397", "/xmlui/handle/10347/9602", "/xmlui/handle/10347/11485", "#", "/xmlui/", "/xmlui/handle/10347/6394", "/xmlui/handle/10347/6397", "/xmlui/handle/10347/9602", "/xmlui/handle/10347/11485", "/xmlui/bitstream/handle/10347/29818/2022_tfg_medicina_pino_manifestaciones.pdf?sequence=1&isAllowed=y", "/xmlui/browse?value=Pino+L%C3%B3pez%2C+Rosal%C3%ADa+del+Carmen&type=author", "/xmlui/browse?value=Sope%C3%B1a+P%C3%A9rez-Arg%C3%BCelles%2C+Bernardo&type=author", "/xmlui/browse?value=Freire+Dapena%2C+Mar%C3%ADa+del+Carmen&type=author", "/xmlui/browse?value=D%C3%A9ficit+selectivo+de+IgA&type=subject", "/xmlui/browse?value=Covid-19&type=subject", "/xmlui/browse?value=Alergia&type=subject", "/xmlui/browse?value=Enfermedad+cel%C3%ADaca&type=subject", "/xmlui/browse?value=Autoinmunidad&type=subject", "/xmlui/browse?value=Alerxia&type=subject", "/xmlui/browse?value=Enfermidade+cel%C3%ADaca&type=subject", "/xmlui/browse?value=Autoinmunidade&type=subject", "/xmlui/browse?value=Selective+IgA+deficiency&type=subject", "/xmlui/browse?value=Allergy&type=subject", "/xmlui/browse?value=Celiac+Disease&type=subject", "/xmlui/browse?value=Autoimmunity&type=subject", "http://hdl.handle.net/10347/29818", "/xmlui/handle/10347/11485", "http://www.mendeley.com/import/?url=http://hdl.handle.net/10347/29818", "http://www.refworks.com/express/ExpressImport.asp?filter=Refworks%20Tagged%20Format&vendor=minerva%40usc.es&url=https://minerva.usc.es/proxy/refworks.jsp?handle=10347/29818", "http://scholar.google.es/scholar?as_occt=title&as_q=Manifestaciones cl%C3%ADnicas y respuesta al COVID-19 en adultos con d%C3%A9ficit completo de inmunoglobulina A", "http://sfx.bugalicia.org/san?&rft.atitle=Manifestaciones+cl%C3%ADnicas+y+respuesta+al+COVID-19+en+adultos+con+d%C3%A9ficit+completo+de+inmunoglobulina+A&rft.aulast=Pino+L%C3%B3pez&rft.aufirst=Rosal%C3%ADa+del+Carmen&rft.date=2022-06", "/xmlui/handle/10347/29818?show=full", "", "http://creativecommons.org/licenses/by-nc-sa/4.0/", "http://www.europeana.eu/portal/", "http://roai.mcu.es/", "http://www.americanae.es/", "http://www.tesisenred.net/handle/10803/35688", "http://recolecta.fecyt.es", "http://www.base-search.net/", "https://www.openaire.eu/", "http://www.sherpa.ac.uk/romeo/", "http://www.accesoabierto.net/dulcinea/", "http://roar.eprints.org/", "http://www.opendoar.org/", "/xmlui/contact", "/xmlui/feedback", "/xmlui/htmlmap", null, "/xmlui/community-list", "/xmlui/browse?type=dateissued", "/xmlui/browse?type=author", "/xmlui/browse?type=title", "/xmlui/browse?type=subject", null, "/xmlui/handle/10347/11485/browse?type=dateissued", "/xmlui/handle/10347/11485/browse?type=author", "/xmlui/handle/10347/11485/browse?type=title", "/xmlui/handle/10347/11485/browse?type=subject", "/xmlui/login", "/xmlui/register", "/xmlui/handle/10347/29818/statistics", "http://www.europeana.eu/portal/", "http://roai.mcu.es/", "http://www.americanae.es/", "http://www.tesisenred.net/handle/10803/35688", "http://recolecta.fecyt.es", "http://www.base-search.net/", "https://www.openaire.eu/", "http://www.sherpa.ac.uk/romeo/", "http://www.accesoabierto.net/dulcinea/", "http://roar.eprints.org/", "http://www.opendoar.org/", "/xmlui/contact", "/xmlui/feedback", "/xmlui/htmlmap"]}